Literature DB >> 28245730

Peripheral nervous system injury after high-dose single-fraction image-guided stereotactic radiosurgery for spine tumors.

Michael D Stubblefield1, Katarzyna Ibanez2, Elyn R Riedel3, Ori Barzilai4, Ilya Laufer4,5, Eric Lis6, Yoshiya Yamada7, Mark H Bilsky4,5.   

Abstract

OBJECTIVE The object of this study was to determine the percentage of high-dose (1800-2600 cGy) single-fraction stereotactic radiosurgery (SF-SRS) treatments to the spine that result in peripheral nervous system (PNS) injury. METHODS All patients treated with SF-SRS for primary or metastatic spine tumors between January 2004 and May 2013 and referred to the Rehabilitation Medicine Service for evaluation and treatment of neuromuscular, musculoskeletal, or functional impairments or pain were retrospectively identified. RESULTS Five hundred fifty-seven SF-SRS treatments in 447 patients resulted in 14 PNS injuries in 13 patients. All injures resulted from SF-SRS delivered to the cervical or lumbosacral spine at 2400 cGy. The overall percentage of SF-SRS treatments resulting in PNS injury was 2.5%, increasing to 4.5% when the thoracic spine was excluded from analysis. The median time to symptom onset following SF-SRS was 10 months (range 4-32 months). The plexus (cervical, brachial, and/or lumbosacral) was affected clinically and/or electrophysiologically in 12 (86%) of 14 cases, the nerve root in 2 (14%) of 14, and both in 6 (43%) of 14 cases. All patients experienced pain and most (93%) developed weakness. Peripheral nervous system injuries were CTCAE Grade 1 in 14% of cases, 2 in 64%, and 3 in 21%. No dose relationship between SF-SRS dose and PNS injury was detected. CONCLUSIONS Single-fraction SRS to the spine can result in PNS injury with major implications for function and quality of life.

Entities:  

Keywords:  CTCAE = Common Terminology Criteria for Adverse Events; DRG = dorsal root ganglion; EGFR = epidermal growth factor; EMG = electromyography; GTV = gross tumor volume; PNS = peripheral nervous system; PTV = planning treatment volume; SF-SRS = single-fraction stereotactic radiosurgery; VEGF = vascular endothelial growth factor; complications; peripheral nerve; radiosurgery; spine

Mesh:

Year:  2017        PMID: 28245730      PMCID: PMC5546836          DOI: 10.3171/2016.11.FOCUS16348

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  35 in total

1.  Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors.

Authors:  Dirk Rades; Stefan Huttenlocher; Amira Bajrovic; Johann H Karstens; Irenaeus A Adamietz; Nadja Kazic; Volker Rudat; Steven E Schild
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-27       Impact factor: 7.038

2.  High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions.

Authors:  Yoshiya Yamada; Mark H Bilsky; D Michael Lovelock; Ennapadam S Venkatraman; Sean Toner; Jared Johnson; Joan Zatcky; Michael J Zelefsky; Zvi Fuks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-01-30       Impact factor: 7.038

3.  Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.

Authors:  Christine Collen; Ben Ampe; Thierry Gevaert; Maarten Moens; Nadine Linthout; Mark De Ridder; Dirk Verellen; Jean D'Haens; Guy Storme
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-12       Impact factor: 7.038

4.  Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases.

Authors:  Amit K Garg; Almon S Shiu; James Yang; Xin-Shelley Wang; Pamela Allen; Barry W Brown; Patricia Grossman; Erik K Frija; Mary Frances McAleer; Syed Azeem; Paul D Brown; Laurence D Rhines; Eric L Chang
Journal:  Cancer       Date:  2012-04-17       Impact factor: 6.860

5.  Brachial plexus lesions in patients with cancer: 100 cases.

Authors:  S H Kori; K M Foley; J B Posner
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

6.  Spinal cord tolerance for stereotactic body radiotherapy.

Authors:  Arjun Sahgal; Lijun Ma; Iris Gibbs; Peter C Gerszten; Sam Ryu; Scott Soltys; Vivian Weinberg; Shun Wong; Eric Chang; Jack Fowler; David A Larson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-16       Impact factor: 7.038

7.  Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites.

Authors:  Jeffrey A Forquer; Achilles J Fakiris; Robert D Timmerman; Simon S Lo; Susan M Perkins; Ronald C McGarry; Peter A S Johnstone
Journal:  Radiother Oncol       Date:  2009-05-18       Impact factor: 6.280

8.  Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases.

Authors:  Peter S Rose; Ilya Laufer; Patrick J Boland; Andrew Hanover; Mark H Bilsky; Josh Yamada; Eric Lis
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

Review 9.  Late radiation injury to peripheral nerves.

Authors:  Pierre-François Pradat; Sylvie Delanian
Journal:  Handb Clin Neurol       Date:  2013

10.  Preliminary results of high-dose single-fraction radiotherapy for the management of chordomas of the spine and sacrum.

Authors:  Yoshiya Yamada; Ilya Laufer; Brett W Cox; D Michael Lovelock; Robert G Maki; Joan M Zatcky; Patrick J Boland; Mark H Bilsky
Journal:  Neurosurgery       Date:  2013-10       Impact factor: 4.654

View more
  4 in total

Review 1.  Appropriate endpoints for stereotactic body radiotherapy for bone metastasis: Classification into five treatment groups.

Authors:  Kei Ito; Naoki Nakamura; Takuya Shimizuguchi; Hiroaki Ogawa; Katsuyuki Karasawa
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-18

Review 2.  Preclinical Risk Evaluation of Normal Tissue Injury With Novel Radiosensitizers.

Authors:  Sonja Dragojevic; Jianxiong Ji; Pankaj K Singh; Margaret A Connors; Robert W Mutter; Scott C Lester; Surabhi M Talele; Wenjuan Zhang; Brett L Carlson; Nicholas B Remmes; Sean S Park; William F Elmquist; Sunil Krishnan; Erik J Tryggestad; Jann N Sarkaria
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-08-14       Impact factor: 7.038

3.  Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy.

Authors:  J John Lucido; Trey C Mullikin; Feven Abraha; W Scott Harmsen; Birjoo D Vaishnav; Debra H Brinkmann; Roman O Kowalchuk; Joseph T Marion; Benjamin A Johnson-Tesch; Omar El Sherif; Paul D Brown; Peter S Rose; Dawn Owen; Jonathan M Morris; Mark R Waddle; Brittany L Siontis; Bradley J Stish; Deanna H Pafundi; Nadia N Laack; Kenneth R Olivier; Sean S Park; Kenneth W Merrell
Journal:  Adv Radiat Oncol       Date:  2022-08-13

4.  Brachial plexopathy after stereotactic body radiation therapy for apical lung cancer: Dosimetric analysis and preliminary clinical outcomes.

Authors:  Sumit S Sood; Christopher McClinton; Rajeev Badkul; Nathan Aguilera; Fen Wang; Allen M Chen
Journal:  Adv Radiat Oncol       Date:  2017-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.